ProCE Banner Activity

When Patients With Chronic HBV Infection Do Not Meet Indications for Immediate Treatment: The Critical Role of Ongoing Monitoring

Podcast Episodes
In this podcast, CCO’s expert faculty discusses how to identify which patients with chronic HBV infection may not need immediate HBV treatment and the critical need to continue monitoring such patients even in the absence of ongoing therapy.

Released: May 26, 2022

Expiration: May 25, 2023

Share

Faculty

Pietro Lampertico

Pietro Lampertico, MD, PhD

Professor of Gastroenterology
Director, Division of Gastroenterology and Hepatology
IRCCS Ca Granda Policlinico Hospital
University of Milan
Milan, Italy

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

AbbVie

Gilead Sciences, Inc.

Partners

ALF

ProCE Banner

Faculty Disclosure

Primary Author

Pietro Lampertico, MD, PhD

Professor of Gastroenterology
Director, Division of Gastroenterology and Hepatology
IRCCS Ca Granda Policlinico Hospital
University of Milan
Milan, Italy

Pietro Lampertico, MD, PhD, has disclosed that he has received consulting fees from AbbVie, Aligos, Antios, Eiger, Gilead Sciences, GlaxoSmithKline, Janssen, and Myr Pharma.